Monday - January 26, 2026

Category Archives: Business

Car T Cell Therapy For Multiple Myeloma Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | Bluebird bio, Cellectis SA, Caribou Biosciences

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Car T Cell Therapy For Multiple Myeloma pipeline constitutes 5+ key companies continuously working towards developing 5+ Car T Cell Therapy For Multiple Myeloma treatment therapies, analysis of Clinical Trials, … Continue reading →

Pancreatic Cancer Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Dragonfly Therapeutics, Keymed B, Tango Therapeutics, Atara Biotherapeutics, Keymed Biosciences Co. Ltd

The Key Pancreatic Cancer Companies in the market include – AstraZeneca, Merck Sharp & Dohme, Actuate Therapeutics, Dragonfly Therapeutics, Keymed B, Tango Therapeutics, Atara Biotherapeutics, Keymed Biosciences Co.Ltd, Carisma Therapeutics Inc, Cue Biopharma, Bold Therapeutics, Purple Biotech Ltd, ENB Therapeutics, … Continue reading →

Data Index, an independent job platform for UK data science roles, finds data science hiring concentrating around defined use cases as organisations tighten experimentation into delivery

Data Index reviews UK data science job ad language and explains the move toward defined use cases, measurable impact, and production delivery. UK data jobs platform, Data Index, reviews how data science roles are being described and why listings increasingly … Continue reading →

Global Benzene Market is projected to reach 71.18 million tons by 2031 driven by strong demand in Asia-Pacific Region | Mordor Intelligence

benzene market According to Mordor Intelligence, Benzene Market Size, Share & Trends Forecast 2026-2031,” offers an in-depth analysis of the regional dynamics shaping this rapidly evolving industry. The benzene market size is estimated at 59.21 million tons in 2026 and … Continue reading →

Chronic Urticaria Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Chronic Urticaria Pipeline Insight, 2025” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in the Chronic Urticaria pipeline landscape. It covers the Chronic Urticaria pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →